ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases. PROtrol […]

BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

PROtrol is the only whole organism reference material to provide complete testing data. Each lot of product is supplied with the protein concentration and TCID50 value, which minimizes qualification testing. PROtrol provides better reproducibility, which optimizes the use of financial spending and processing time through the decreased need for repeat testing.

ZeptoMetrix logo

“The rapid expansion in development of antigen-based assays has highlighted some quality challenges. Inactivated, whole organism controls designed specifically for antigen tests can equip manufacturers with the tools they need to better evaluate the performance of their assays, leading to higher quality tests on the market,” said Dr. Karuna Sharma, Vice President & Chief Scientific Officer.

PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers seeking to expand access to inexpensive and easy-to-use diagnostics.

“The launch and expansion of PROtrol enhances our position as the partner of choice for diagnostic test developers,” said Evangeline Gonzalez, President of Antylia Diagnostics division. “As we work with our diagnostic partners, ZeptoMetrix is pleased with the role that PROtrol plays to give patients around the world more access to diagnostic testing.”

More information on how to order the new PROtrol and additional ZeptoMetrix products can be found at: https://www.zeptometrix.com

About ZeptoMetrix®
ZeptoMetrix® is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

Links:
* (PROSARS(COV2)-587): product page
https://www.zeptometrix.com/products/protrolt-sars-cov-2-isolate-usa-wa1-2020-1-ml

Contact Information

Andrew Zenger
Global Product Manager
andrew.zenger@antylia.com
(716) 715-7417

Related Files

PROSARS(COV2)-587 Product Insert.pdf
ZeptoMetrix Launches PROtrol.pdf

SOURCE: ZeptoMetrix

Previous Article

Impulse Dynamics Announces 9,000th Patient Milestone Achieved With CCM® Therapy for Heart Failure

Next Article

Zoom Partners with Anthropic to Expand Federated Approach to AI

Related Posts

‫شبكة تلفزيون الصين الدولية (CGTN): تخفض الصين من إجراءات كوفيد-19 حيث تستعد الأمة للحياة الطبيعية

بكين، 9 يناير/كانون الثاني 2023 / PRNewswire / — وضعت الصين إجراءاتها المخففة لكوفيد-19 حيز التنفيذ يوم الأحد حيث بدأت الأمة في استئناف الحياة الطبيعية بعد ثلاث سنوات من الإدارة الصارمة للوباء. أعادت الدولة فتح موانئها الحدودية لنقل البضائع وكذلك للزوار الوافدين والمغادرين. كما استأنفت خدماتها للمواطنين الصينيين لتقديم طلبات الحصول على جوازات سفر وتأشيرات للعمل والاستجمام. […]

Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor

Xencor receives rights to additional equity in Zenas as upfront payment and is eligible for up to $480 million in potential milestone payments and royalties on net sales of commercialized products Obexelimab is a novel bifunctional antibody with first-in-class potential to treat autoimmune diseases MONROVIA, Calif., HONG KONG and BOSTON, Nov. 21, 2021 (GLOBE NEWSWIRE) […]

SCENTAIR® Announces Global Partnership with Snap Fitness

Snap Fitness, partners with ScentAir to elevate member experience. CHARLOTTE, N.C., July 7, 2021 /PRNewswire/ — ScentAir, the global leader in scent marketing, announced today its partnership with leading fitness franchise Snap Fitness. Rated among the Best 10 Gym Franchises in the US for 2021 according to TopFranchise.com, Snap Fitness has nearly 2,000 locations open or […]

‫شركة ريتشارد أتياس وشركاؤه (RA&A) تُعلِن عن استراتيجية عالمية لعام 2022 وفريق قيادة جديد

– قامت شركة ريتشارد أتياس وشركاؤه (Richard Attias & Associates) – وهي إحدى شركات الاتصالات الاستراتيجية الرائدة في العالم وإحدى شركات التقييم الفني للمنصات – بإعادة ترتيب وتنظيم ما تقدمه من خدمات حول خمس خبرات أساسية من أجل دعم صانعي السياسات والحكومات والشركات والمؤسسات خلال هذا الوقت من التغيير الغير مسبوق. – سيعزز تحول RA&A قدرتها على […]